110 STAT. 3112 PUBLIC LAW 104-237—OCT. 3, 1996 42 USC 290aa-4 note. 21 USC 872a. Establishment. 21 USC 801 note. (f) TERMINATION.—The interagency task force shall terminate 4 years after the date of enactment of this Act. SEC. 502. PUBLIC HEALTH MONITORING. The Secretary of Health and Human Services shall develop a public health monitoring program to monitor methamphetamine abuse in the United States. The program shall include the collection and dissemination of data related to methamphetamine abuse which can be used by public health officials in policy development. SEC. 503. PUBLIC-PRIVATE EDUCATION PROGRAM. (a) ADVISORY PANEL. —The Attorney General shall establish an advisory panel consisting of an appropriate number of representatives from Federal, State, and local law enforcement and regulatory agencies with experience in investigating and prosecuting illegal transactions of precursor chemicals. The Attorney General shall convene the panel as often as necessary to develop and coordinate educational programs for wholesale and retail distributors of precursor chemicals and supplies. (b) CONTINUATION OF CURRENT EFFORTS. — The Attorney General shall continue to— (1) maintain an active program of seminars and training to educate wholesale and retail distributors of precursor chemicals and supplies regarding the identification of suspicious transactions and their responsibility to report such transactions; and (2) provide assistance to State and local law enforcement and regulatory agencies to facilitate the establishment and maintenance of educational programs for distributors of precursor chemicals and supplies. SEC. 504. SUSPICIOUS ORDERS TASK FORCE. (a) IN GENERAL. —The Attorney General shall establish a "Suspicious Orders Task Force" (the "Task Force") which shall consist of— (1) appropriate personnel from the Drug Enforcement Administration (the "DEA") and other Federal, State, and local law enforcement and regulatory agencies with the experience in investigating and prosecuting illegal transactions of listed chemicals and supplies; and (2) representatives from the chemical and pharmaceutical industry. (b) RESPONSIBILITIES.—The Task Force shall be responsible for developing proposals to define suspicious orders of listed chemicals, and particularly to develop quantifiable parameters which can be used by registrants in determining if an order is a suspicious order which must be reported to DEA. The quantifiable parameters to be addressed will include fi-equency of orders, deviations from prior orders, and size of orders. The Task Force shall also recommend provisions as to what types of payment practices or unusual business practices shall constitute prima facie suspicious orders. In evaluating the proposals, the Task Force shall consider effectiveness, cost and feasibility for industry and government, and other relevant factors. (c) MEETINGS.— The Task Force shall meet at least two times Eer year and at such other times as may be determined necessary y the Task Force.
�
